Patent Granted And Revoked: Indian Patent Office Flip-Flop On Humira Worries Patent Experts
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Drug maker Abbott is caught in a peculiar situation over its Humira (adalimumab) patent in India. The Indian Patent Office is reported to have granted a patent for the blockbuster drug used in the treatment of rheumatoid arthritis but then unilaterally moved to revoke it just a month later